Doses of the AstraZeneca and Oxford vaccine, in a file image DADO RUVIC / Reuters
Brazilian health authorities have announced this Wednesday that a volunteer who was participating in the Oxford vaccine trials has died.
Without giving further details, the Brazilian National Health Surveillance Agency has assured that the tests of the vaccine developed by the British University of Oxford and the AstraZeneca company will continue despite the death of the man.
The O'Globo newspaper maintains that the deceased is a 28-year-old Brazilian volunteer, who died of complications from covid-19.
Anonymous sources have assured the newspaper that he received doses of placebo, not the vaccine.
It also says that the Brazilian health authorities were informed of the death on Monday and that the International Committee for the Safety Analysis of the trial recommended to go ahead with it.
Information about the coronavirus
- Here you can follow the last hour on the evolution of the pandemic
- This is how the coronavirus curve evolves in the world
- Download the tracking application for Spain
- Search engine: The new normal by municipalities
- Guide to action against the disease